Yoshiro Nakahara

4PUBLICATIONS
23CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 01, 2026
MET Dependence Oversteps EGFR Dependence via Balancing Dimerization of the Receptor Tyrosine Kinases in Osimertinib-Resistant MET-Amplified, EGFR-Mutated Non-Small Cell Lung Cancer.

|Nov 17, 2022
Promising Response to Dabrafenib Plus Trametinib in a Patient with Peritoneal Carcinomatosis from Non Small Lung Cancer Harboring BRAF V600E Mutation.

Yuri Yagami, Yoshiro Nakahara, Hideaki Manabe

|Aug 18, 2022
A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non-Small Cell Lung Cancer: TORG1630.

Yuri Taniguchi, Tsuneo Shimokawa, Yuichi Takiguchi

|Jun 06, 2018
A promising response to osimertinib in a patient with erlotinib-resistant lung adenocarcinoma with an uncommon EGFR mutation.

Hideyuki Niwa, Yoshiro Nakahara, Jiichiro Sasaki

Pageof 1

Frequent Collaborators

3 joint publications

Katsuhiko Naoki

2 joint publications

Takashi Sato

1 joint publications

Yuri Taniguchi

1 joint publications

Tsuneo Shimokawa